Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Atlanta, Georgia 30329


A novel procedure for generalized anxiety disorder where an odorant cue is paired with the state of deep relaxation during training. It is hypothesized that by smelling the odor in an anxiety-provoking situation, the patient will more easily invoke a state of relaxation, providing greater relief from the distressing tension and worry that characterize GAD.

Study summary:

We hypothesize that by presenting a novel odor to a patient in a state of deep relaxation, the odor will serve as a conditioned inhibitory stimulus, or safety signal, in anxiety-provoking situations. With the odor serving as a contextual cue for the state of relaxation.


Inclusion Criteria: - GAD without a comorbid active major psychiatric disorder. - GAD must be the primary active psychiatric disorder. - GAD determined via the Mini International Neuropsychiatric Interview (MINI). Exclusion Criteria: - Significant medical illness that might interfere with the relaxation therapy or with training using the odorant. - Actively abusing alcohol. - Illicit substances. - Currently using rapid-acting anxiolytic agents (e.g. benzodiazepines, hydroxyzine). - Started an antidepressant, antipsychotic or mood stabilizing agent within three months of screening visit.



Primary Contact:

Principal Investigator
Philip T Ninan, MD
Emory University

Backup Contact:


Location Contact:

Atlanta, Georgia 30329
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.